wonder how many characters in the subject? here we go from our last friend dollarchamp.https://www.businesswire.com/news/home/20110413005979/en/Research-Markets-Bladder-Cancer---Global-DrugGemcitabine was the top-selling drug in the bladder cancer therapeuticsmarket in 2010. The other leading drugs in the market in 2001 were BCGtherapy and methotrexate which registered sales of $55m and $57m. In2010, gemcitabine was the leading drug in the bladder cancertherapeutics market, with sales of $170m. Methotrexate and BCG therapywere the other leading therapies with sales of $145m and $131m. Between2010 and 2020, three promising therapies, Javlor (vinflunine), Urocidin(intravesical formulation of Mycobacterial cell wall-DNA complex (MCC))and EOquin (apaziquone), are expected to hit the market. Between 2010and 2020, the market is expected to be led by Urocidin, with forecastsales of $386m.Post #29597269 side effect from gemcitabine:https://www.google.ca/url?sa=t&rct=j&q=gemcitabine%20side%20effects%20pdf%20bc%20cancer&source=web&cd=1&ved=0CBsQFjAA&url=http%3A%2F%2Fwww.bccancer.bc.ca%2FNR%2Frdonlyres%2F61DCBA09-705A-485C-9058-05B892064E80%2F50942%2Fgemcitabine_monograph_6June2011.pdf&ei=WMTPTq3WCYOIiALotOG6BQ&usg=AFQjCNGQUpibRdIvbAXvx_It-vqkdxAQdw&cad=rja